Zucchetti M - Search Results

1

A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma.

Gallerani E, Zucchetti M, Brunelli D, Marangon E, Noberasco C, Hess D, Delmonte A, Martinelli G, Böhm S, Driessen C, De Braud F, Marsoni S, Cereda R, Sala F, D'Incalci M, Sessa C. Gallerani E, et al. Among authors: zucchetti m. Eur J Cancer. 2013 Jan;49(2):290-6. doi: 10.1016/j.ejca.2012.09.009. Epub 2012 Oct 8. Eur J Cancer. 2013. PMID: 23058787 Review.

2

Activity of aphidicolin glycinate alone or in combination with cisplatin in a murine ovarian tumor resistant to cisplatin.

Damia G, Tagliabue G, Zucchetti M, Davoli E, Sessa C, Cavalli F, D'Incalci M. Damia G, et al. Among authors: zucchetti m. Cancer Chemother Pharmacol. 1992;30(6):459-64. doi: 10.1007/BF00685597. Cancer Chemother Pharmacol. 1992. PMID: 1394802

3

Phase I and clinical pharmacological evaluation of aphidicolin glycinate.

Sessa C, Zucchetti M, Davoli E, Califano R, Cavalli F, Frustaci S, Gumbrell L, Sulkes A, Winograd B, D'Incalci M. Sessa C, et al. Among authors: zucchetti m. J Natl Cancer Inst. 1991 Aug 21;83(16):1160-4. doi: 10.1093/jnci/83.16.1160. J Natl Cancer Inst. 1991. PMID: 1886148 Clinical Trial.

4

Phase I study of the antifolate N10-propargyl-5,8-dideazafolic acid, CB 3717.

Sessa C, Zucchetti M, Ginier M, Willems Y, D'Incalci M, Cavalli F. Sessa C, et al. Among authors: zucchetti m. Eur J Cancer Clin Oncol. 1988 Apr;24(4):769-75. doi: 10.1016/0277-5379(88)90313-6. Eur J Cancer Clin Oncol. 1988. PMID: 3383977

5

Lack of effect of cisplatin on i.v. L-PAM plasma pharmacokinetics in ovarian cancer patients.

Zucchetti M, D'Incalci M, Willems Y, Cavalli F, Sessa C. Zucchetti M, et al. Cancer Chemother Pharmacol. 1988;22(1):87-9. doi: 10.1007/BF00254189. Cancer Chemother Pharmacol. 1988. PMID: 3396150

6

Pharmacokinetics of etoposide in patients with abnormal renal and hepatic function.

D'Incalci M, Rossi C, Zucchetti M, Urso R, Cavalli F, Mangioni C, Willems Y, Sessa C. D'Incalci M, et al. Among authors: zucchetti m. Cancer Res. 1986 May;46(5):2566-71. Cancer Res. 1986. PMID: 3697995

7

Pharmacokinetics of teniposide in patients with ovarian cancer.

D'Incalci M, Rossi C, Sessa C, Urso R, Zucchetti M, Farina P, Mangioni C. D'Incalci M, et al. Among authors: zucchetti m. Cancer Treat Rep. 1985 Jan;69(1):73-7. Cancer Treat Rep. 1985. PMID: 3967261

8

Pharmacokinetic study of VM26 given as a prolonged IV infusion to ovarian cancer patients.

Rossi C, Zucchetti M, Sessa C, Urso R, Mangioni C, D'Incalci M. Rossi C, et al. Among authors: zucchetti m. Cancer Chemother Pharmacol. 1984;13(3):211-4. doi: 10.1007/BF00269031. Cancer Chemother Pharmacol. 1984. PMID: 6488441

9

Phase I clinical and pharmacokinetic study of oral etoposide phosphate.

Sessa C, Zucchetti M, Cerny T, Pagani O, Cavalli F, De Fusco M, De Jong J, Gentili D, McDaniel C, Prins C, et al. Sessa C, et al. Among authors: zucchetti m. J Clin Oncol. 1995 Jan;13(1):200-9. doi: 10.1200/JCO.1995.13.1.200. J Clin Oncol. 1995. PMID: 7799021 Clinical Trial.

10

High-performance liquid chromatographic assay for the determination of the novel podophyllotoxin derivative dimethylaminoetoposide (NK611) in human plasma.

Zucchetti M, De Fusco M, Sessa C, Fröhlich A, Reichert S, D'Incalci M. Zucchetti M, et al. J Chromatogr B Biomed Appl. 1994 Mar 18;654(1):97-102. doi: 10.1016/0378-4347(93)e0453-w. J Chromatogr B Biomed Appl. 1994. PMID: 8004249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters